NCBI NLM ID: 101683470
Cancer is a group of diseases results in abnormal cell growth with the ability to invade or spread to other parts of the body. Not all tumors are cancerous; benign tumors do not spread to other parts of the body. The symptoms of the disease includes new lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. Cancer Clinical trials are research studies carried out on human volunteers to test the efficacy of a new drug or procedures. These studies are mainly conducted to prevent, detect or treat cancer.
Journal of Cancer Clinical Trials is a Scholarly Open Access journal that deals with the study of cancer research and publishes original research articles, reviews, short reports, mini reviews, and letters to the editor. The Journal consider articles on all types of cancer clinical trials, including cancer clinical trials, including breast cancer, lung cancer, ovarian cancer, liver cancer, bladder cancer, prostate cancer, blood cancer, colon cancer, cervical cancer, skin cancer, oesophagal cancer, kidney cancer, brain cancer, metastatic breast cancer, osteosarcoma, oncology, cancer clinical trials and ethical issues, glioblastoma, cancer clinical trials management, etc.
Journal of Cancer Clinical Trial: Open access is using Editor Tracking System to maintain the quality of the online manuscript submission and peer review process. Review processing is performed by the editorial board members of the Journal or by outside experts. At least two independent reviewers approval followed by editor's approval is mandatory for acceptance of any citable manuscript.
Hilaris SRL is a leading Open Access publisher that publishes more than 700 leading-edge peer reviewed Open Access Journals and organizes over 1000 International Conferences globally with the support of nearly 1000 International Societies. Hilaris SRLjournals cater to over 3 million readers with the support of 50000 eminent personalities as editorial board members.
Submit manuscript at https://www.scholarscentral.org/submissions/cancer-clinical-trials.html or send as an e-mail attachment to the Editorial Office at [email protected]
Ait Taleb OumÃ¢ÂÂhand Hajar*, Mahiou Noureddine , Belhaj Najoua, Nitassi Sophia, Bencheikh Razika, Benbouzid M A, Oujilal Abdelilah and Essakalli Leila